Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure
Patent
1993-04-05
1995-10-24
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
4241651, 514192, 514200, A61K 3940, A61K 3943, A61K 3174, A61K 31545, A61K 31675
Patent
active
054608139
ABSTRACT:
The invention relates to various methodologies for diagnosing Kawasaki syndrome. Various bacteria, including TSST-1 producing Staphylococcus aureus, and SPEB and SPEC producing streptococcus have been found to be indicative of the pathological condition. Also described is a Kawasaki syndrome implicated isolate of S. aureus, and therapeutic methodologies for preventing treating the condition. These involve the administration of anti-TSST-1 agents which are not gamma globulin.
REFERENCES:
Boventre et al., "Toxic of Recombinant Toxic Shock Syndrome Toxin 1 and Mutant Toxins Produced by Staphyloccus aureus in a Rabbit Infection Model of Toxic Shock Syndrome", Infect. & Immun. 61(3): 793-799 (Mar. 1993).
Rich et al., "Intravaenous IgG: Supertherapy for Superantigens?", J. Clin. Invest. 91: 378 (1993).
Takei et al., "Intravenous Immunoglobulin Contains Specific Antibodies Inhibitory to Activation of T Cells by Staphylococcal Toxin Superantigens", J. Clin. Invest. 91: 602-607 (Feb. 1993).
Bonventre et al., "Neutralization of Toxic Shock Syndrome Toxin-1 by Monoclonal Antibodies in vitro and in vivo", Infect. & Immun. 56(1): 135-141 (Jan. 1988).
Fulton David
Kotzin Brian
Leung Donald
Meissner Cody
Schlievert Patrick
Goldberg Jerome D.
National Jewish Center for Immunology and Respiratory Medicine
LandOfFree
Method for treating Kawasaki syndrome by administration of an an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating Kawasaki syndrome by administration of an an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating Kawasaki syndrome by administration of an an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1884991